# Mechanistic bridges from receptors to whole-brain dynamics: promise and limits of master-equation mean-field models

Preprint · Yannael Bossard, Lahna Bekri, Alain Destexhe

- Archive id: arxiv:2608.00306
- Published: 2026-07-31
- arXiv: https://arxiv.org/abs/2608.00306
- Citations: 0
- Source URL: https://arxiv.org/abs/2608.00306
- PDF: https://arxiv.org/pdf/2608.00306
- Provenance: arxiv

## Abstract

Many pharmacological and pathological perturbations arise at molecular, synaptic, or cellular scales, but are observed through population and whole-brain signals. Cross-scale reductions must preserve relevant mechanisms while remaining tractable. This review asks which microscopic mechanisms remain explicit, interpretable, and testable after reduction, and what claims these models support. Using receptor-aware adaptive mean fields from the master-equation lineage as a worked case, we trace finite-size population statistics and semi-analytical transfer functions into conductance-based adaptive nodes coupled through the connectome. We compare this strategy with phenomenological neural masses, low-dimensional and population-density reductions, large-scale spiking models, and learned or hybrid surrogates, including computational work and memory traffic. Receptor-dependent synaptic kinetics, conductance state, and spike-frequency adaptation can remain manipulable across scales, enabling interpretable interventions and testable mesoscopic and macroscopic consequences. However, this relies on coarse-grained Markovianity, population homogeneity, quasi-stationary transfer functions, moment closure, regional uniformity, and measurement-specific observation models. First-order implementations discard covariance dynamics, while macroscopic agreement cannot identify a unique molecular cause. Node-local biological detail mainly changes prefactors, whereas dense global covariances change the scaling class. Cross-scale models should therefore be judged by the interventions and observables they preserve, validity domain, identifiability, empirical adequacy, and computational burden. Receptor-aware mean fields are not universal, but offer a transparent, tractable strategy for selected mechanistic questions when each reduction step is independently validated.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Connectomics & Brain Mapping](https://space-kitty.com/topics/connectomics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.